Oxidized immunoglobulin G in patients with end-stage renal disease treated by hemodialysis

Annals of Clinical and Laboratory Science

Volumn 33, Issue 1, 2003, Pages 11-17

  Ahmed, Shahid ^a   Gibbons, Nora ^a   Mattana, Joseph ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Hemodialysis; Immunoglobulin G; Oxidative stress

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMODIALYSIS; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; KIDNEY FAILURE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; WESTERN BLOTTING;

BLOTTING, WESTERN; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; KIDNEY FAILURE, CHRONIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PAPAIN; RENAL DIALYSIS;

EID: 0037412479     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Haag-Weber M, Horl WH. The immune system in uremia and during its treatment. New Horiz 1995;3:669-679.
2. Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 1993;3:1541-1554.
3. Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 1996;16:192-201.
4. Cohen G, Haag-Weber M, Horl WH. Immune dysfunction in uremia. Kidney Int 1997;62(suppl): S79-S82.
5. Maher ER, Wickens DG, Griffin JF, Kyle P, Curtis JR, Dormandy TL. Increased free-radical activity during hemodialysis? Nephrol Dial Transplant 1987;2:169-171.
6. Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 1995;48:199-206.
7. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57:10-15.
8. Toborek M, Tomasz W, Drozdz M, et al. Effect of haemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992;41:1229-1232.
9. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 1992;60:56-59.
10. Paul J-L, Sall N-D, Soni T, et al. Lipid peroxidation abnormalities in hemodialysis patients. Nephron 1993;64:106-109.
11. Peuchant E, Carbonneau MA, Dubourg L, et al. Lipoperoxidation in plasma and red blood cells of patients undergoing hemodialysis: Vitamins A, E and iron status. Free Rad Biol Med 1994;6:339-346.
12. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM. Neoplasms in dialysis patients. Am J Kidney Dis 1989;14:119-123.
13. Linder A, Farewell VT, Sherrard DJ. High incidence of neoplasia in uremic patients receiving long-term dialysis. Nephron 1981;27:292-296.
14. Berlett BS, Stadtman ER. Protein oxidation in aging, disease and oxidative stress. J Biol Chem 1997;272:20313-20316.
15. Oliver CN, Ahn B, Moerman EJ, Goldstein S, Stadtman ER. Age-related changes in oxidized proteins. J Biol Chem 1987;262:5488-5491.
16. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Ahn B-W, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990;186:464-478.
17. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA. Oxidative damage to brain proteins, loss of glutamine synthetase activity and production of free radicals during ischemia/reperfusion injury to gerbil brain. Proc Natl Acad Sci USA 1990;87:5144-5147.
18. Lenz A-G, Ulrich C, Shaltiel S, Levine RL. Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal Biochem 1989;177:419-425.
19. Oliver CN. Inactivation of enzymes and oxidative modification of proteins by stimulated neutrophils. Arch Biochem Biophys 1987;253:62-72.
20. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
21. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drueke TB, Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999;14(Suppl 1):76-78.
22. Descamps-Latscha B, Witko-Sarsat V. Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl 2001;78:S108-S113.
23. Odetti P, Garibaldi S, Gurreri G, Aragno I, Dapino D, Pronzato MA, Marinari UM. Protein oxidation in hemodialysis and kidney transplantation. Metabolism 1996;45:1319-1322.
24. Shacter E, Williams JA, Lim M, Levine RL. Differential susceptibility of plasma proteins to oxidative modification: Examination by Western blot immunoassay. Free Rad Biol Med 1994;17:429-437.
25. Margiloff L, Chaplia L, Chow A, Singhal PC, Mattana J. Metal-catalyzed oxidation of immunoglobulin G impairs Fc receptor-mediated binding to macrophages. Free Rad Biol Med 1998;25:780-785.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
27. Dolhofer-Bliesener R, Lechner B, Gerbitz KD. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation. Eur J Clin Chem Clin Biochem 1994;32:329-336.
28. Dolhofer-Bliesner R, Gerbitz KD. Impairment by glycation of immunoglobulin G Fc fragment function. Scand J Clin Lab Invest 1990;50:739-746.